Walgreens’ VillageMD Bet: A Healthcare Roll-Up That Scaled Before It Proved Itself

Walgreens paid $5.2B for VillageMD control, backed an $8.9B physician roll-up, then wrote down $15.4B. What add-on acquirers should prove first.